Call to Action: Protecting Our Communities from Unsafe Obesity Treatments

Choose Healthy Life (CHL) is committed to addressing obesity as a serious and life-threatening disease that disproportionately impacts the communities we serve. Expanding access to effective, evidence-based anti-obesity medications is essential. But access must never come at the expense of safety.

FDA-approved therapies for obesity, including GLP-1 medications, have been scientifically proven to be safe and effective when prescribed and used appropriately. These innovations are transforming lives. However, we are deeply concerned by the growing number of companies marketing compounded and unregulated versions of these drugs that are not FDA-approved, may differ in formulation, dosage, or purity, and expose consumers to serious health risks without their full understanding.

CHL stands with the National Consumer League and other consumer and public health advocates in calling for greater accountability, transparency, and oversight of these compounded products. Our communities deserve accurate information, safe treatment options, and protection from misleading or dangerous practices.

We urge policymakers, regulators, health leaders, and faith-based partners to:

• Strengthen enforcement against unregulated and misleading obesity treatments

• Ensure consumers are fully informed about the risks of non-FDA-approved compounded medications

• Protect equitable access to safe, proven, FDA-approved therapies for obesity

Obesity is a chronic disease. Our response must be rooted in science, safety, justice, and access for all. CHL will continue to advocate for responsible solutions that safeguard the health and dignity of the communities we serve.